Charles Sawyers, MD
Enriched profileChair, Human Oncology and Pathogenesis Program; Marie-Josée and Henry R. Kravis Chair; HHMI Investigator · Memorial Sloan Kettering Cancer Center
Charles Sawyers is Chair, Human Oncology and Pathogenesis Program; Marie-Josée and Henry R. Kravis Chair; HHMI Investigator at Memorial Sloan Kettering Cancer Center. OpenAlex indexes 639 publications with 104,223 citations (h-index 131); ClinicalTrials.gov lists 4 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 1% of Hematology / Oncology profiles in the findmyKOL directory. Clarivate lists Charles Sawyers as a Highly Cited Researcher (Clinical Medicine, 2014-2015; Cross-Field, 2018-2022).
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Charles Sawyers, MD, is Chair, Human Oncology and Pathogenesis Program at Memorial Sloan Kettering Cancer Center. The public record shows 639 publications with 104,223 citations (h-index 131), centered on Leukemia (AML/ALL/CML/CLL), Prostate Cancer. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 8 companies, 9 NIH-funded awards (2007–2026).
- Most recent indexed publication: 2026 · Nature
- Top research focus: Leukemia (AML/ALL/CML/CLL)
- 4 registered trials on ClinicalTrials.gov
- Open Payments reporting from 8 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 40 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingPublic positions
sourced statements on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗
- Appointed by President Obama to the National Cancer Advisory Board (NCAB)
2012; later chaired NCAB Subcommittee on Planning and Budget
2012verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:
- Dasatinib in Treating Patients With Chronic Myelogenous Leukemia or Acute Lymphoblastic Leukemia
Sponsor: Jonsson Comprehensive Cancer Center
- 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Did Not Respond to Imatinib Mesylate
Sponsor: Jonsson Comprehensive Cancer Center
- Neoadjuvant CCI-779 Followed By Radical Prostatectomy in Treating Patients With Newly Diagnosed Prostate Cancer Who Have a High Risk of Relapse
Sponsor: Jonsson Comprehensive Cancer Center
Industry payments
Updated 27 Aug 2026
8 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- GENZYME CORPORATIONProgram year20252 payments$1,271,522openpaymentsdata.cms.gov ↗
- Blueprint Medicines CorporationProgram year20254 payments$15,835openpaymentsdata.cms.gov ↗
- BeOne Medicines USA, Inc.Program year20253 payments$11,667openpaymentsdata.cms.gov ↗
NIH funding
Updated 27 Aug 2026
9 NIH research awards on record, funded 2007–2026 per NIH RePORTER. The latest:
- Project 1: Investigation of immune and stromal factors that promote prostate adenocarcinoma progression and castration response
Columbia University Health Sciences
FY2026$507,659P01CA265768 - Leveraging Observational (Real World) Data to Advance Precision Oncology
Sloan-Kettering Inst Can Research
FY2025$2,357,014P01CA275746 - Project 1: Investigation of immune and stromal factors that promote prostate adenocarcinoma progression and castration response
Columbia University Health Sciences
FY2025$487,709P01CA265768
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Deconvolving SARS-CoV-2 mRNA vaccine impact on immunotherapy-related survival.
Cancer discovery
Article2026 - Targeting Tumor Microenvironment-Derived NRG1-HER2/3 Signaling with Zenocutuzumab Restores Sensitivity to AR Inhibition in PTEN Wild-type Prostate Cancer.
Molecular cancer therapeutics
Article2026
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- LinkedIn
linkedin.com/in/charles-sawyers-b8a8b517
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
Mentions by others
where others cite or feature them- LinkedIn
linkedin.com/posts/memorial-sloan-kettering-cancer-center_twenty-years-ago-msks-dr-charles-sawyers-activity-6872901080292892672-QoDi
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗ - Other
mskcc.org/podcasts/cancer-straight-talk/future-of-cancer-drugs-conversation-with-dr-charles-sawyers
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →mskcc.org ↗ - X / Twitter
x.com/MSKCancerCenter/status/2041199385829163121
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗
- Internal medicine residency
University of California, San Francisco
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aacr.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗
- Past President
American Society for Clinical Investigation (ASCI)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →the-asci.org ↗
Highly Cited Researcher
Clarivate's annual list, by award category and year- Clinical Medicine20142015verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →clarivate.com ↗
- Cross-Field20182019202020212022verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →clarivate.com ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗
- 2009 Lasker-DeBakey Clinical Medical Research Award (shared with Brian J. Druker and Nicholas Lydon)
for development of imatinib and dasatinib for CML
2009verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →laskerfoundation.org ↗ - Elected member
National Academy of Sciences
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nasonline.org ↗
Secondary affiliations
appointments beyond the home institution- Professor
Cell and Developmental Biology Program, Weill Cornell Graduate School of Medical Sciences
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →gradschool.weill.cornell.edu ↗ - Faculty listing
Weill Cornell Medicine directory
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →directory.weill.cornell.edu ↗ - Board of Scientific Counselors (Chairman)
Broad Institute of MIT and Harvard
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →broadinstitute.org ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗
- Featured researcher
PBS/Ken Burns documentary "Cancer: The Emperor of All Maladies"
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cancerhistoryproject.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Howard Scher, MD
Memorial Sloan Kettering Cancer Center
Robert Motzer, MD
Memorial Sloan Kettering Cancer Center
Valerie Rusch, MD
Memorial Sloan Kettering Cancer Center
Mark Kris, MD
Memorial Sloan Kettering Cancer Center